Aki von Roy
Signal active
Venture Partner
Bio
Widely experienced multi-national pharmaceutical executive in multiple countries, with a bent in later life to life science start-ups
Current & previous Board roles include: Chairman of CuroNZ, Genesis R&D, Phytomedics, Phylogica, Dentman AG and Bionik World; Director of Wool Equities, Corra Life Sciences, Encoate, Cortech, Source MDx and Biomatters, plus involvement in 18 other biotech/hi-tech startups including PhotoNZ, Cytran and Sepracor; partner, Inventages life science VC fund
Previous roles include: President, Europe for Bristol-Myers Squibb; Schering AG (now Bayer Pharma) in the UK, NZ, Sweden, USA and Germany; Founding CEO of Proacta and CoDa Therapeutics
Location
N/A
Social
Primary Organization
BioPacific Ventures
Founded
2005
Investment
5
Lead investment
1
Exits
0
Employees
1-10
Industry
Venture Capital, Finance, Banking
Jobs history
0
N/A
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Aki von Roy is the Venture Partner at BioPacific Ventures. With a background in Venture Capital, Aki von Roy has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
N/A
Number of investment
1
Number of exits
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
0
There is no partner investment available on this profile
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.